News

People with multiple sclerosis (MS) may have slightly shorter-than-average life spans, depending on disease severity, ...
An international Phase 2 trial will test BMS-986368 as a potentially new oral therapy for managing multiple sclerosis-related ...
Panelists discuss how BTK inhibitors represent a promising new oral therapy class that could address both inflammatory and ...
Autoimmune diseases, such as multiple sclerosis (MS), inflammatory bowel disease (IBD), and rheumatoid arthritis (RA), affect ...
DelveInsight’s, “Multiple Sclerosis Pipeline Insight 2025” report provides comprehensive insights about 75+ companies and 80+ ...
Mesenchymal stem cell therapy lessens disability and brain lesions in MS patients, according to a review of published studies ...
Some vitamins and herbal supplements may help to relieve MS symptoms, but others are ineffective and might even be harmful. Learn which is which.
New biomarkers enhance multiple sclerosis (MS) diagnosis, enabling earlier detection and improved patient care, transforming MS management across the health care system.
In relapsing-remitting multiple sclerosis, activation of the peripheral immune system can lead to focal inflammation within the CNS. Over the past three decades, therapeutic development has been ...
Autoimmune diseases, like multiple sclerosis result when the body’s immune system starts to attack its own cells. Regulatory ...
The common food additive that's linked to autoimmune disease and this ingredient hiding in your pantry could be triggering ...
Dr. Simrit Parmar, a Northwestern University-trained oncologist and research scientist, launched Cellenkos Inc., in 2016 to ...